[1] Ferrone S,Whiteside TL.Tumor microenvironment and immune escape[J].Surg Oncol Clin N Am,2007,16(4):755-774.
[2] Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL22 receptor α-chains(CD25).Break down of single mechanism of self-tolerance causes various autoimmune disease[J].J Immunol,1995,155(3):1151-1164.
[3] Ormandy LA,Hillemann T,Wedemeyer H,et al.Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J].Cancer Res,2005,65(6):2457-2464.
[4] Xu T,Duan Q,Wang G,et al.CD4+ CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy[J].Cell Biochem Biophys,2011,61(2):389-392.
[5] 唐聃,杨伟明,姚新生,等.乳腺癌患者外周血CD4+ CD25+Foxp3+调节性T 细胞水平的检测及意义[J].中国普通外科杂志,2014,23(5):612-617.
[6] 周利敏,李红英,张敦兰,等.调节性T细胞在宫颈癌外周血及肿瘤组织中的检测及其相关性研究[J].海南医学院学报,2014,20(7):899-901.
[7] Xu H,Mao Y,Dai Y,et al.CD4+ CD25+ regulatory T cells in patients with advanced gastrointestinal cancer treated with chemotherapy[J].Onkologie,2009,32(5):246-252.
[8] 梁建明,钟永,蔡建强,等.胰腺癌患者外周血CD4+CD25high调节性T细胞分析[J].蚌埠医学院学报,2009,34(10):878-881.
[9] Tokuno K,Hazama S,Yoshino S,et al.In creased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer[J].Anticancer Res,2009,29(5):1527-1532.